Earnings Call · Q3 FY2022·2022-11-10

Q3 22EPS +26.09%·Rev n/aQ2 22EPS +9.52%·Rev n/aQ1 22EPS +18.18%·Rev n/aQ4 21EPS +13.04%·Rev n/a⚠ consensus missing

CorMedix Inc. CRMD

Daniel Ferry — Investor Relations (inferred from context)

Joe Todisco — Chief Executive Officer

Phoebe Mounts — Executive Vice President, General Counsel and Head of Technical Operations

Matt David — Executive Vice President and CFO

+9.2%1d on move date+3.7% vs SPY3d+35.0%5d+30.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRMD calls or request research access.

More CRMD calls Browse calls Request research access